HHSN26100041: Leidos Biomedical Research Inc · FederalPipeline
HHSN26100041: Leidos Biomedical Research Inc
Delivery Order to Leidos Biomedical Research Inc by National Institutes of Health: $15.2M obligated, latest action 2023-11-30. Igf::ot::igf Human Tumor…